logo
#

Latest news with #ZydusLifesciencesLtd.

Stock market update: Nifty Pharma index  falls  0.93%
Stock market update: Nifty Pharma index  falls  0.93%

Time of India

time22-05-2025

  • Business
  • Time of India

Stock market update: Nifty Pharma index falls 0.93%

NEW DELHI: The Nifty Pharma index closed on a negative note on Thursday. Shares of Zydus Lifesciences Ltd.(up 1.56 per cent), J B Chemicals & Pharmaceuticals Ltd.(up 0.86 per cent) and Natco Pharma Ltd.(up 0.2 per cent) ended the day as top gainers in the pack. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like If You Eat Ginger Everyday for 1 Month This is What Happens Tips and Tricks Undo On the other hand, Mankind Pharma Ltd.(down 3.65 per cent), Ajanta Pharma Ltd.(down 2.45 per cent), Torrent Pharmaceuticals Ltd.(down 2.35 per cent), Biocon Ltd.(down 2.22 per cent) and Ipca Laboratories Ltd.(down 1.94 per cent) finished as the top losers of the day. The Nifty Pharma index closed 0.93 per cent down at 21521.75. Benchmark NSE Nifty50 index ended down 203.75 points at 24609.7, while the BSE Sensex stood down 644.64 points at 80951.99. Live Events Among the 50 stocks in the Nifty index, 8 ended in the green, while 42 closed in the red. Shares of Vodafone Idea, Tata Teleservices, NTPC Green Energy, YES Bank and Tata Steel were among the most traded shares on the NSE. Shares of Interarch Building, Stampede Cap(DVR), India Glycols, Solar Ind. and SecMark Consultancy hit their fresh 52-week highs in today's trade, while Aditya Birla Retail, R K Swamy, California Soft(PP), Chembond Chem and Career Point hit their fresh 52-week lows.

Indices: Stock market update: Nifty Pharma index falls 0.93%
Indices: Stock market update: Nifty Pharma index falls 0.93%

Time of India

time22-05-2025

  • Business
  • Time of India

Indices: Stock market update: Nifty Pharma index falls 0.93%

The Nifty Pharma index closed 0.93 per cent down at 21521.75. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads NEW DELHI: The Nifty Pharma index closed on a negative note on of Zydus Lifesciences Ltd.(up 1.56 per cent), J B Chemicals & Pharmaceuticals Ltd.(up 0.86 per cent) and Natco Pharma Ltd.(up 0.2 per cent) ended the day as top gainers in the the other hand, Mankind Pharma Ltd.(down 3.65 per cent), Ajanta Pharma Ltd.(down 2.45 per cent), Torrent Pharmaceuticals Ltd.(down 2.35 per cent), Biocon Ltd.(down 2.22 per cent) and Ipca Laboratories Ltd.(down 1.94 per cent) finished as the top losers of the Nifty Pharma index closed 0.93 per cent down at NSE Nifty50 index ended down 203.75 points at 24609.7, while the BSE Sensex stood down 644.64 points at the 50 stocks in the Nifty index, 8 ended in the green, while 42 closed in the of Vodafone Idea, Tata Teleservices, NTPC Green Energy, YES Bank and Tata Steel were among the most traded shares on the of Interarch Building, Stampede Cap(DVR), India Glycols, Solar Ind. and SecMark Consultancy hit their fresh 52-week highs in today's trade, while Aditya Birla Retail, R K Swamy, California Soft(PP), Chembond Chem and Career Point hit their fresh 52-week lows.

Stock market update: Nifty Pharma index falls 0.93%
Stock market update: Nifty Pharma index falls 0.93%

Economic Times

time22-05-2025

  • Business
  • Economic Times

Stock market update: Nifty Pharma index falls 0.93%

NEW DELHI: The Nifty Pharma index closed on a negative note on Thursday. ADVERTISEMENT Shares of Zydus Lifesciences Ltd.(up 1.56 per cent), J B Chemicals & Pharmaceuticals Ltd.(up 0.86 per cent) and Natco Pharma Ltd.(up 0.2 per cent) ended the day as top gainers in the pack. On the other hand, Mankind Pharma Ltd.(down 3.65 per cent), Ajanta Pharma Ltd.(down 2.45 per cent), Torrent Pharmaceuticals Ltd.(down 2.35 per cent), Biocon Ltd.(down 2.22 per cent) and Ipca Laboratories Ltd.(down 1.94 per cent) finished as the top losers of the day. The Nifty Pharma index closed 0.93 per cent down at 21521.75. Benchmark NSE Nifty50 index ended down 203.75 points at 24609.7, while the BSE Sensex stood down 644.64 points at 80951.99. Among the 50 stocks in the Nifty index, 8 ended in the green, while 42 closed in the red. ADVERTISEMENT Shares of Vodafone Idea, Tata Teleservices, NTPC Green Energy, YES Bank and Tata Steel were among the most traded shares on the NSE. Shares of Interarch Building, Stampede Cap(DVR), India Glycols, Solar Ind. and SecMark Consultancy hit their fresh 52-week highs in today's trade, while Aditya Birla Retail, R K Swamy, California Soft(PP), Chembond Chem and Career Point hit their fresh 52-week lows. ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)

Zydus receives EIR from USFDA for its Ambernath API manufacturing facility
Zydus receives EIR from USFDA for its Ambernath API manufacturing facility

Business Upturn

time14-05-2025

  • Business
  • Business Upturn

Zydus receives EIR from USFDA for its Ambernath API manufacturing facility

By Aman Shukla Published on May 14, 2025, 12:48 IST Zydus Lifesciences Ltd. has announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) manufacturing facility located in Ambernath, Maharashtra. The inspection was conducted by the USFDA from February 10 to 14, 2025. Following the inspection, the facility received no observations , indicating full compliance with current Good Manufacturing Practices (cGMP). The USFDA has classified the outcome as No Action Indicated (NAI) , which is the most favorable classification for such inspections. In the exchange filing, the company shared, 'We wish to inform that the company has received the EIR report from the USFDA for the inspection conducted at its API manufacturing facility located at Ambernath, Maharashtra. This facility underwent an inspection from 10th to 14th February 2025, and had ended with NIL observations. The EIR report has classified it as No Action Indicated (NAI).' This successful outcome reinforces Zydus' strong commitment to maintaining global regulatory standards and ensuring quality manufacturing practices across all its facilities. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store